Samuel George A. III 4
4 · Lineage Cell Therapeutics, Inc. · Filed Mar 12, 2025
Insider Transaction Report
Form 4
Samuel George A. III
General Counsel and Secretary
Transactions
- Award
Employee Stock Option (Right to Buy)
2025-03-10+750,000→ 750,000 totalExercise: $0.53Exp: 2035-03-10→ Common Shares (750,000 underlying)
Footnotes (1)
- [F1]One quarter of the options shall vest on March 10, 2026, and the balance shall vest in 36 monthly installments thereafter upon the completion of each month of continuous employment.